These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

260 related articles for article (PubMed ID: 31247995)

  • 1. From Discovery of Snake Venom Disintegrins to A Safer Therapeutic Antithrombotic Agent.
    Kuo YJ; Chung CH; Huang TF
    Toxins (Basel); 2019 Jun; 11(7):. PubMed ID: 31247995
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Anti-thrombotic agents derived from snake venom proteins.
    Huang TF; Hsu CC; Kuo YJ
    Thromb J; 2016; 14(Suppl 1):18. PubMed ID: 27766044
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Snake venom disintegrins: classification and therapeutic potential].
    Kallech-Ziri O; Luis J; El Ayeb M; Marrakchi N
    Arch Inst Pasteur Tunis; 2007; 84(1-4):29-37. PubMed ID: 19388581
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Preclinical studies of a novel snake venom-derived recombinant disintegrin with antitumor activity: A review.
    Schönthal AH; Swenson SD; Chen TC; Markland FS
    Biochem Pharmacol; 2020 Nov; 181():114149. PubMed ID: 32663453
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Snake venom metalloproteinase containing a disintegrin-like domain, its structure-activity relationships at interacting with integrins.
    Lu X; Lu D; Scully MF; Kakkar VV
    Curr Med Chem Cardiovasc Hematol Agents; 2005 Jul; 3(3):249-60. PubMed ID: 15974889
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A Novel α
    Kuo YJ; Chung CH; Pan TY; Chuang WJ; Huang TF
    Toxins (Basel); 2019 Dec; 12(1):. PubMed ID: 31877725
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Preferential antagonism of the interactions of the integrin alpha IIb beta 3 with immobilized glycoprotein ligands by snake-venom RGD (Arg-Gly-Asp) proteins. Evidence supporting a functional role for the amino acid residues flanking the tripeptide RGD in determining the inhibitory properties of snake-venom RGD proteins.
    Lu X; Williams JA; Deadman JJ; Salmon GP; Kakkar VV; Wilkinson JM; Baruch D; Authi KS; Rahman S
    Biochem J; 1994 Dec; 304 ( Pt 3)(Pt 3):929-36. PubMed ID: 7529494
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Purification and characterization of a new RGD/KGD-containing dimeric disintegrin, piscivostatin, from the venom of Agkistrodon piscivorus piscivorus: the unique effect of piscivostatin on platelet aggregation.
    Okuda D; Morita T
    J Biochem; 2001 Sep; 130(3):407-15. PubMed ID: 11530017
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Disintegrins: potent inhibitors of platelet aggregation].
    Perutelli P
    Recenti Prog Med; 1995 Apr; 86(4):168-74. PubMed ID: 7617961
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Functional characteristic of snake venom disintegrins: potential therapeutic implication.
    Marcinkiewicz C
    Curr Pharm Des; 2005; 11(7):815-27. PubMed ID: 15777236
    [TBL] [Abstract][Full Text] [Related]  

  • 11. FcgammaRII mediates platelet aggregation caused by disintegrins and GPIIb/IIIa monoclonal antibody, AP2.
    Huang TF; Chang CH; Ho PL; Chung CH
    Exp Hematol; 2008 Dec; 36(12):1704-13. PubMed ID: 18809237
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Contortrostatin, a snake venom disintegrin with anti-angiogenic and anti-tumor activity.
    Swenson S; Costa F; Ernst W; Fujii G; Markland FS
    Pathophysiol Haemost Thromb; 2005; 34(4-5):169-76. PubMed ID: 16707922
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The integrin alpha IIb beta 3 contains distinct and interacting binding sites for snake-venom RGD (Arg-Gly-Asp) proteins. Evidence that the receptor-binding characteristics of snake-venom RGD proteins are related to the amino acid environment flanking the sequence RGD.
    Rahman S; Lu X; Kakkar VV; Authi KS
    Biochem J; 1995 Nov; 312 ( Pt 1)(Pt 1):223-32. PubMed ID: 7492316
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Snake venoms and the hemostatic system.
    Markland FS
    Toxicon; 1998 Dec; 36(12):1749-800. PubMed ID: 9839663
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Crystal structure of trimestatin, a disintegrin containing a cell adhesion recognition motif RGD.
    Fujii Y; Okuda D; Fujimoto Z; Horii K; Morita T; Mizuno H
    J Mol Biol; 2003 Oct; 332(5):1115-22. PubMed ID: 14499613
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Anti-angiogenesis and RGD-containing snake venom disintegrins.
    Swenson S; Ramu S; Markland FS
    Curr Pharm Des; 2007; 13(28):2860-71. PubMed ID: 17979731
    [TBL] [Abstract][Full Text] [Related]  

  • 17. From Snake Venom's Disintegrins and C-Type Lectins to Anti-Platelet Drugs.
    Lazarovici P; Marcinkiewicz C; Lelkes PI
    Toxins (Basel); 2019 May; 11(5):. PubMed ID: 31137917
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Thrombolytic effects of the snake venom disintegrin saxatilin determined by novel assessment methods: a FeCl3-induced thrombosis model in mice.
    Kwon I; Hong SY; Kim YD; Nam HS; Kang S; Yang SH; Heo JH
    PLoS One; 2013; 8(11):e81165. PubMed ID: 24260554
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Mechanistic insights of snake venom disintegrins in cancer treatment.
    Akhtar B; Muhammad F; Sharif A; Anwar MI
    Eur J Pharmacol; 2021 May; 899():174022. PubMed ID: 33727054
    [TBL] [Abstract][Full Text] [Related]  

  • 20. How snake venom disintegrins affect platelet aggregation and cancer proliferation.
    Kolvekar N; Bhattacharya N; Sarkar A; Chakrabarty D
    Toxicon; 2023 Jan; 221():106982. PubMed ID: 36435228
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.